Chembio Stock Market Sentiment

CEMI
 Stock
  

USD 0.86  0.01  1.18%   

Chembio investor sentiment overview provides quick insight into current market opportunities from investing in Chembio Diagnostics. The current market sentiment together Chembio Diagnostics' historical and current headlines can help investors to time the market. Many technical investors use Chembio Diagnostics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Chembio Diagnostics Hype Analysis, Chembio Diagnostics Correlation and Chembio Diagnostics Performance.
  
Chembio Diagnostics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Chembio daily returns and investor perception about the current pice of Chembio Diagnostics as well as its diversification or hedging effects on your existing portfolios.

Chembio Diagnostics Sentiment by Major News Outlets

benzinga news
news
news
news
Macroaxis News: globenewswire.com
businessinsider News

Chembio Diagnostics Twitter Pulse

Investors have realized that leveraging social media to get the fastest information affecting stock prices isn't a theory anymore, it is a reality, and Twitter offers a platform that can outpace even the most trustworthy news aggregators. The influence of social media outlets on stock markets and stock prices of entities such as Chembio Diagnostics has been proven in recent years. We extract public sentiment from Twitter posts that could be utilized to determine whether Chembio Diagnostics' prices will increase or decrease.
Twitter's metrics such as likes, followers, and engagement can be good indicators of the reliance and probability of reaction to a specific tweet regarding Chembio Diagnostics. Our Twitter sentiment analysis of Chembio Stock helps investors make informed decisions by leveraging the power of the community. It is a perfect supplementary tool for any beginner or an experienced trader.
over a week ago at stockhouse.com         
2022-08-04 NDAQCEMI Press Release Chembio Diagnostics Inc. - Stockhouse
Macroaxis News: stockhouse.com
over three weeks ago at www.marketscreener.com         
Chembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022 - Marketscreen...
Macroaxis News: marketscreener.com
over three weeks ago at www.defenseworld.net         
Chembio Diagnostics, Inc. Short Interest Update - Defense World
news
over three weeks ago at www.defenseworld.net         
StockNews.com Begins Coverage on Chembio Diagnostics - Defense World
news
over a month ago at www.digitaljournal.com         
Major Player in the Point-of-Care or Rapid Diagnostics Market Witnessing an Increase While the Coron...
news
over a month ago at www.defenseworld.net         
Chembio Diagnostics Coverage Initiated by Analysts at StockNews.com - Defense World
news
over a month ago at indiandefencenews.info         
Rapid Test Kits Market 2022 Study An Emerging Hint of Opportunity Cellex, Abbott, Roche Indian Defen...
news
over a month ago at www.macroaxis.com         
Acquisition by Tesolichtman Leslie of 82286 shares of Chembio Diagnostics subject to Rule 16b-3
Macroaxis News
over a month ago at www.gurufocus.com         
Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors - GuruFocus...
Gurufocus Stories at Macroaxis
over a month ago at www.defenseworld.net         
Chembio Diagnostics Receives New Coverage from Analysts at StockNews.com - Defense World
news
over a month ago at www.benzinga.com         
Global HIV Diagnostics Test Market to Surpass US 8,487.17 Million by 2030 - Coherent Market Insights...
benzinga news
over a month ago at indiandefencenews.info         
Diagnostic Tests Market 2022 to 2029 Competitive Analysis Cellex, Abbott, Roche Indian Defence News ...
news
over a month ago at www.marketscreener.com         
Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel - Marketscreener.co...
Macroaxis News: marketscreener.com
over two months ago at finance.yahoo.com         
Infectious Disease Diagnostics Market worth 33.1 billion by 2027 - Exclusive Report by MarketsandMar...
Yahoo News
over two months ago at www.defenseworld.net         
Chembio Diagnostics Now Covered by StockNews.com - Defense World
news
Far too much social signal, news, headlines, and media speculation about Chembio Diagnostics that are available to investors today. That information is available publicly through Chembio media outlets and privately through word of mouth or via Chembio internal channels. However, regardless of the origin, that massive amount of Chembio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Chembio Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Chembio Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Chembio Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Chembio Diagnostics alpha.

Chembio Diagnostics Performance against DOW

 Price Growth (%)  
       Timeline  
1
Acquisition by Tesolichtman Leslie of 41143 shares of Chembi...05/26/2022
2
Chembio Diagnostics Announces Expansion of Direct-to-Consume...06/15/2022
3
Chembio Diagnostics Receives New Coverage from Analysts at S...06/22/2022
4
Acquisition by Tesolichtman Leslie of 82286 shares of Chembi...06/29/2022
5
EPS Estimate06/30/2022
6
StockNews.com Begins Coverage on Chembio Diagnostics - Defen...07/15/2022
7
EPS Reported08/04/2022
Continue to Chembio Diagnostics Hype Analysis, Chembio Diagnostics Correlation and Chembio Diagnostics Performance. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
25.7 M
Quarterly Revenue Growth YOY
0.42
Return On Assets
-0.3
Return On Equity
-2.06
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.